James Chalmers to Female
This is a "connection" page, showing publications James Chalmers has written about Female.
Connection Strength
0.177
-
The Impact of the COVID-19 Pandemic on Exacerbations and Symptoms in Bronchiectasis: A Prospective Study. Am J Respir Crit Care Med. 2021 10 01; 204(7):857-859.
Score: 0.013
-
Pulmonary rehabilitation after exacerbation of bronchiectasis: a pilot randomized controlled trial. BMC Pulm Med. 2019 May 06; 19(1):85.
Score: 0.011
-
The impact of acute air pollution fluctuations on bronchiectasis pulmonary exacerbation: a case-crossover analysis. Eur Respir J. 2018 07; 52(1).
Score: 0.010
-
Bronchiectasis: a case-based approach to investigation and management. Eur Respir Rev. 2018 Sep 30; 27(149).
Score: 0.010
-
Characterization of the "Frequent Exacerbator Phenotype" in Bronchiectasis. Am J Respir Crit Care Med. 2018 06 01; 197(11):1410-1420.
Score: 0.010
-
"The missing ingredient": the patient perspective of health related quality of life in bronchiectasis: a qualitative study. BMC Pulm Med. 2018 May 22; 18(1):81.
Score: 0.010
-
Assessing the healthcare resource use associated with inappropriate prescribing of inhaled corticosteroids for people with chronic obstructive pulmonary disease (COPD) in GOLD groups A or B: an observational study using the Clinical Practice Research Datalink (CPRD). Respir Res. 2018 04 11; 19(1):63.
Score: 0.010
-
The independent contribution of Pseudomonas aeruginosa infection to long-term clinical outcomes in bronchiectasis. Eur Respir J. 2018 02; 51(2).
Score: 0.010
-
Genetic mannose binding lectin deficiency is associated with airway microbiota diversity and reduced exacerbation frequency in COPD. Thorax. 2018 06; 73(6):510-518.
Score: 0.010
-
Evaluation of severity score-guided approaches to macrolide use in community-acquired pneumonia. Eur Respir J. 2017 09; 50(3).
Score: 0.010
-
Determinants of initial inhaled corticosteroid use in patients with GOLD A/B COPD: a retrospective study of UK general practice. NPJ Prim Care Respir Med. 2017 Jun 29; 27(1):43.
Score: 0.010
-
Anti-Pseudomonas aeruginosa IgG antibodies and chronic airway infection in bronchiectasis. Respir Med. 2017 07; 128:1-6.
Score: 0.009
-
Bronchiectasis Rheumatoid Overlap Syndrome Is an Independent Risk Factor for Mortality in Patients With Bronchiectasis: A Multicenter Cohort Study. Chest. 2017 06; 151(6):1247-1254.
Score: 0.009
-
Middle East respiratory syndrome: the need for better evidence in severe respiratory viral infections. Crit Care Med. 2015 Jun; 43(6):1344-6.
Score: 0.008
-
COVID-19, individual wellbeing and multi-dimensional poverty in the state of South Australia. PLoS One. 2021; 16(6):e0252898.
Score: 0.003
-
Economic burden of bronchiectasis in Germany. Eur Respir J. 2019 02; 53(2).
Score: 0.003
-
Inhaled liposomal ciprofloxacin in patients with non-cystic fibrosis bronchiectasis and chronic lung infection with Pseudomonas aeruginosa (ORBIT-3 and ORBIT-4): two phase 3, randomised controlled trials. Lancet Respir Med. 2019 03; 7(3):213-226.
Score: 0.003
-
The effect of changes to GOLD severity stage on long term morbidity and mortality in COPD. Respir Res. 2018 Dec 12; 19(1):249.
Score: 0.003
-
A comprehensive approach to lung function in bronchiectasis. Respir Med. 2018 12; 145:120-129.
Score: 0.003
-
Burden and risk factors for Pseudomonas aeruginosa community-acquired pneumonia: a multinational point prevalence study of hospitalised patients. Eur Respir J. 2018 08; 52(2).
Score: 0.003
-
Immunological corollary of the pulmonary mycobiome in bronchiectasis: the CAMEB study. Eur Respir J. 2018 07; 52(1).
Score: 0.003
-
Burden of pneumococcal community-acquired pneumonia in adults across Europe: A literature review. Respir Med. 2018 04; 137:6-13.
Score: 0.003
-
Identification of Pseudomonas aeruginosa and airway bacterial colonization by an electronic nose in bronchiectasis. Respir Med. 2018 03; 136:111-117.
Score: 0.003
-
The BRICS (Bronchiectasis Radiologically Indexed CT Score): A Multicenter Study Score for Use in Idiopathic and Postinfective Bronchiectasis. Chest. 2018 05; 153(5):1177-1186.
Score: 0.002
-
Severe Pneumococcal Pneumonia Causes Acute Cardiac Toxicity and Subsequent Cardiac Remodeling. Am J Respir Crit Care Med. 2017 09 01; 196(5):609-620.
Score: 0.002
-
High endocan levels are associated with the need for mechanical ventilation among patients with severe sepsis. Eur Respir J. 2017 07; 50(1).
Score: 0.002
-
A Randomized Controlled Trial of Atorvastatin in Patients With Bronchiectasis Infected With Pseudomonas Aeruginosa: A Proof of Concept Study. Chest. 2017 08; 152(2):368-378.
Score: 0.002
-
The heterogeneity of systemic inflammation in bronchiectasis. Respir Med. 2017 06; 127:33-39.
Score: 0.002